We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

148:HKEXSe Gyung Hi Tech Co., Ltd. Analysis

Data as of 2026-03-15 - not real-time

₩4,635.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Se Gyung Hi Tech is trading well below its longer‑term moving averages, with the price sitting under both the short‑term and medium‑term SMA lines and also beneath the 200‑day trend line. The technical picture is bearish, reinforced by a MACD that remains in negative territory and an RSI hovering near the neutral midpoint, while volatility has surged to a high‑ish level and the stock has experienced a steep historical drawdown.
Fundamentally, the company appears undervalued relative to its discounted cash‑flow estimate, which suggests a fair value far above the current market price. However, the balance sheet shows a high debt‑to‑equity ratio, a sizable net cash position but a large negative free‑cash‑flow gap, and earnings are thin enough that the full dividend payout raises questions about sustainability. Investors should weigh the attractive valuation against the weak cash generation and elevated risk profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • bearish technical positioning below key moving averages
  • elevated short‑term volatility and recent price weakness
  • uncertain dividend sustainability given cash flow shortfall

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • valuation gap between market price and DCF fair value
  • large net cash cushion offset by high leverage
  • potential for earnings improvement if free cash flow turns positive

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • significant upside implied by discounted cash‑flow analysis
  • exposure to growing demand for electronic components in Asia
  • need for operational turnaround to stabilize cash generation and dividend policy

Key Metrics & Analysis

Financial Health

Revenue Growth-2.40%
Profit Margin8.93%
ROE1.33%
ROA0.67%
Debt/Equity4.88
Op. Cash Flow₩22.8B
Free Cash Flow₩-83441172480
Industry P/E33.7

Technical Analysis

TrendBearish
RSI48.9
Support₩3,835.00
Resistance₩5,190.00
MA 20₩4,718.25
MA 50₩4,834.20
MA 200₩5,730.80
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

Fair Value₩8,685.32
GradeUndervalued
TypeValue
Dividend Yield2.16%

Risk Assessment

Beta0.54
Volatility64.59%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.